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Abstract 
Telehealth has become a very important tool that allows the monitoring of heart failure 
patients in a home environment. However, little is known about the effect that such 
monitoring systems have on patients’ compliance, evolution and self-care behaviour. In 
particular, the effect that the selected user interface has on these factors is unknown. This 
study aims to investigate this, and to determine some practicalities that must be 
considered when designing and implementing a telehealth programme for heart failure. 
To achieve this, daily measurements of blood pressure, pulse, SpO2 and weight were 
collected from 534 patients suffering from heart failure. In addition, they were asked to 
fill in the European heart failure self-care behaviour scale questionnaire and the EQ-5D 
quality of life questionnaire, before and after the monitoring period. Two telehealth 
systems were used, the Motiva platform provided by Philips and the standalone unit 
provided by Docobo, the Doc@Home system. Significant differences were found 
between both systems concerning the compliance and adherence of patients. Moreover, 
a general, positive effect of telehealth was identified due to the fact that patients showed 
an increased self-awareness when managing their condition.  These findings are 
supported by behavioural changes and a better understanding of heart failure from the 
patients’ perspective. 
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Introduction 
 
Heart failure (HF) is recognized as one of the most common diseases in Western Europe, 
with more than 10% of the people older than 65 years suffering from it.1 HF represents 
the most common cause of readmission in industrialized countries, and more than 30% 
of patients hospitalized due to HF will die within 1 year.2 It is well known that HF is 
often accompanied by several comorbidities such as coronary artery disease, 
hypertension, atrial fibrillations, and valvular heart disease.3 Therefore, it is not 
surprising that this disease strongly impacts social and economic systems in a large scale. 
For instance, it has been reported that the costs associated with HF represent more than 
2% of the total cost of health care.1 As a result, the use of alternative approaches such as 
telehealth tools that help improving the HF outcome, and reduce the costs, is imminent. 
Even though some telehealth programmes have been implemented for the monitoring of 
HF patients, 4-7 their effect on the entire health care system is not yet understood. For 
example, it has been reported that telehealth seems to be more effective for more critical 
patients and patients with higher risk of hospitalization.8 Hence, it is crucial to identify 
effective protocols that allow to better manage HF.9 In this respect, the Recap (Regional 
Care Portals) project aims to improve and promote the implementation of telehealth 
systems in heart failure.10 This project brings 13 partners from the North West Europe 
region together, to work towards the analysis of new legal, financial, organizational and 
technological solutions in telehealth. These solutions aim to improve the communication 
between patients and care givers, and to increase the awareness of patients with respect 
to the importance of self-managing their condition. With this in mind, it is expected that 
new telehealth solutions could have a positive effect on the diagnosis and treatment of 
HF.  
 
This manuscript deals with technological factors that need to be considered during the 
design and implementation of telehealth programmes in HF. For this reason, three 
partners worked together on the implementation of one of such programmes. One of the 
partners involved in this task is the North East London NHS Foundation Trust (NELFT) 
in the UK, where HF patients were recruited and followed up. Health Enterprise East 
also known as NHS Innovations East in the UK, is the second partner involved in this 
work, which took care of the business planning and commercial research on telehealth 
systems monitoring HF patients. The third partner is the KU Leuven in Belgium, where 
the data analysis took place. Furthermore, KU Leuven evaluated and defined the 
technological practicalities that needed to be considered during the implementation of 
this telehealth programme.  
 
In this study, two different telehealth systems were implemented, namely the Motiva 
platform offered by Philips (The Netherlands), and the standalone unit provided by 
Docobo (UK). Docobo model numbers were as follows: A&D UA-767PBT-C40 BT BP 
Monitor (3PM-A02 SN), A&D UC-321PBT-C40 BT Scales (3PM-A03 SN), 
HealthHUB 2 Roaming GPRS BT Kit (DCU-002-RGPRS-BT), and Nonin 9560 
Bluetooth Oximeter (3PM-N06 SN).  
 
The main differences between these two telehealth systems are the user interface, 
mobility, and the educational information. Therefore, it is possible to assess differences 
between these systems, and determine whether education and mobility have an impact 
on the evolution of HF patients. Another important point investigated in this work is the 
effect of telehealth on the self-care behaviour of patients. With this in mind, the general 
effect of education and self-management will be clarified and hopefully later used in the 
implementation of new telehealth programmes.  
 
 
Methods 
 
Ethics 
 
The study was approved by Health research authority NRES east of England with 
reference number 12/EE/0137. Moreover, each patient signed a written consent form 
before starting the telehealth programme. 
 
 
Patient population 
 
The dataset used in this study consists of daily measurements of blood pressure, pulse, 
blood oxygen saturation (SpO2), and weight, collected from HF patients referred to the 
North East London NHS Foundation Trust (NELFT) in the UK, from November 2012 
to November 2014. All eligible patients were older than 18 years and they all had a 
confirmed diagnosis of left ventricular systolic dysfunction (LVSD) supported by a 
positive ECG. In addition, at least one of the following conditions was satisfied: sudden 
increase in weight of more than 1.5kg in 24 hours; systolic blood pressure lower than 90 
mm Hg; sudden increase in shortness of breath; episodes of palpitation/tachycardia 
without collapse; change of medication within 48 hours of discharge from acute; or high 
Hospital Anxiety Depression Self-Assessment (HADS) score.11 On the other hand, if 
any of the following conditions applied, the patient was excluded from the study: 
diagnosis without ECG; clinically stable NYHA I to II classification (New York Heart 
Association); Nil oedema; normotension (120/80 mm Hg); end of life with NYHA larger 
than II; or insufficient cognitive understanding to complete questionnaires or to use the 
telehealth equipment. 
 
 
Study design 
 
Once a patient was enrolled into the programme, the Hospital Anxiety and Depression 
Scale (HADS) was administered. Next, a demonstration of the use of the telehealth 
programme was provided by the HF nurses, together with the explanation of the EU 
Recap project and the benefits of the whole programme. In total 534 HF patients were 
eligible, with mean age 69.1yr±12.6yr. No record was kept of how many patients had 
declined to participate in the first place. Figure 1 presents the flow of participants in the 
study. All patients were randomized into two groups, one receiving the standalone unit 
offered by Docobo (135 patients), and one receiving the Motiva telehealth platform 
offered by Philips (399 patients). The groups were unevenly split because less Docobo 
systems than Philips Motiva equipment were available for this study, hence more of the 
latter to give to patients. During the first days of monitoring, the patients were trained at 
home, to measure the 5 physiological parameters mentioned above, twice a day, on a 
daily basis. After 42 days of constant monitoring, the telehealth equipment was returned 
to NELFT and it was allocated to a different patient. A monitoring of 42 days was 
selected as the appropriate study period because it has been shown that HF readmissions 
are known to occur within 6 weeks at minimum to 6 months at maximum.12 
 
Apart from the physiological measurements, patients were asked to fill in the European 
heart failure self-care behaviour scale (EHFScBS)13 and the EQ-5D14 quality of life 
questionnaires, at the beginning and at the end of the monitoring period. This was done 
in order to assess changes in self-care behaviour and quality of life followed by the 
telehealth programme. Additionally, the HADS was also administered at the end of each 
trial. Of the 534 patients, 411 (mean age 68.5yr±12.2yr) completed the 42 day 
programme, 123 were females and 288 were males, 105 patients received Docobo units, 
and 306 patients received the Motiva system. All data transferred to KU Leuven for 
analysis was completely anonymized. 
 
Interventions like changes in medication, titrations, and withdrawals were annotated in 
the data. However, no information about type of medication or specific doses was 
available. It is important to mention that all of these interventions were the same for both 
groups, and they were made mainly by the nurses with input from cardiologists and GPs 
where appropriate. Additionally, both groups were monitored by the same healthcare 
providers. 
 
 
The telehealth systems 
 
As mentioned before, two different monitoring systems were deployed, the Docobo unit 
and the Motiva platform. Their main characteristics are indicated in Table 1. The most 
important difference between these two systems relies on the functions that they offer to 
the patients. For instance, the Motiva platform offers more educational material, and a 
more familiar interface, since it is a personal healthcare television channel. In this 
channel, patients can read reminders sent from the health providers, and access videos 
where the importance of a healthy diet, physical activity, and medication is highlighted. 
Even though this information is crucial to encourage patients to stay healthy, no record 
was kept of when and how often the patients accessed and reviewed this material.  
 
On the other hand, the Docobo system used for this study is a stand-alone unit that does 
not provide educational information, but offers more mobility to the patients. The main 
goal of this study is to determine differences on the physiological parameters, and 
answers to questionnaires, for patients with different systems. In the same way, indirect 
effects of the user interface can be assessed. 
 
 
Data analysis 
 
In order to quantify the evolution of the physiological parameters of all HF patients that 
completed the monitoring period of 42 days, the slope (m) for each parameter was 
computed using linear regression. Each patient was then characterized by 5 slopes that 
describe the tendency of each parameter from day 1 to day 42. The slopes for each group 
were compared, and differences were assessed by means of the Kruskal-Wallis test with 
a 95% confidence interval. The reason to use this test is that it does not assume normality 
in the variables, as for instance one-way Anova. Furthermore, the quality of life and the 
self-care behaviour for patients with decreased/increased trends were analysed. From 
this analysis the possible impact of the different telehealth systems on the compliance of 
patients to the programme was determined. Patients’ compliance was also associated 
with the amount of missing data for each telehealth system, and the amount of additional 
data that was transferred to the telehealth programme. The additional data refers to the 
amount of days that patients measured themselves more than twice.  
 
The amount of interventions and the differences between the initial and the final HADS 
per group were also compared. Moreover, differences in age and gender were also 
considered. Differences between proportions were evaluated using the Chi-square test. 
 
All calculations were carried out in MATLAB R2013a on an Intel(R) Core(TM) i7, 
2.4GHz, 8GB RAM, running Windows 8.1. 
 
Results 
 
Initial common problems  
 
The first observations correspond to the initial common issues reported by the patients 
during the installation of the telehealth systems and during the first days of monitoring. 
For instance, patients using the Docobo unit had problems adhering to the monitoring 
times. Additionally, due to the characteristics of the unit, they needed to rely on a care 
giver to be able to collect and transmit the data. Therefore, initial issues concerning the 
daily transmission of the data were commonly reported. On the other hand, patients using 
the Motiva system complained about the portability of the unit. Furthermore, the 
installation of the platform was sometimes not straightforward due to the different TV 
technologies available at the patients’ homes. This resulted in transmission problems of 
the first readouts of the physiological parameters. 
It is important to point out that this information was obtained from the free text patients 
wrote on the surveys and from speaking to the patients. Hence, no statistics can be made 
on these observations. 
 
Patient’s compliance 
 
An important factor to consider when implementing a telehealth system is the amount 
of data transmitted to the care provider, in this instance the HF nursing team. This is 
crucial for the design of algorithms that can predict decompensations related to HF. In 
this study, patients needed to measure themselves twice a day, but it was observed that 
patients using the Motiva system measured themselves significantly (p<<0.05) more 
times a day than patients using the Docobo unit. This is shown in Figure 2, where the 
amount of missing data per group is also indicated.  
 
 
Effect of telehealth on the physiological parameters 
 
The initial comparison was performed between the “baseline” parameters of both groups 
under investigation. Figure 3 indicates the physiological parameters at day 1, and the age 
of all patients. At this point, no significant differences (p>0.05) were found.  
 
The next step was to compare the evolution of the physiological parameters of both 
groups. This was done using the slopes during the monitoring period of 42 days. Figure 
4 shows the differences for each physiological parameter. A decreasing trend was found 
in DBP, pulse and weight, however, only the first one was significantly different with 
p=0.001. 
 
 
Effect of telehealth on quality of life 
 
The questionnaire used to assess changes in the quality of life (QoL) consists of 5 
questions that evaluate the following factors: anxiety/depression; pain/discomfort; usual 
activities (e.g. work, study, housework, and family or leisure activities); self-care; and 
mobility.14 Each factor gets scored according to the severity of the problems experienced 
by the patient. As mentioned before, two scores were obtained, one at day 1 and one at 
day 42. As a result, it was possible to determine whether or not changes in the QoL were 
caused by the telehealth system, and if they were influenced by the user interface. No 
significant differences (p>0.05) were found between the factors at the beginning and at 
the end for either all patients together or for the two groups separately.   
 
A different way of evaluating the anxiety/depression factor is by means of the HADS. 
Here, these scores at the beginning and at the end were also evaluated, and no significant 
differences (p>0.05) were found. 
 
When looking at patients that showed an improved QoL at day 42, no relationship was 
found between this improvement and their evolution during the 42 days of monitoring. 
In other words, these patients did not show a consistent evolution in the physiological 
parameters.  
 
 
Effect of telehealth on self-care behaviour 
 
To assess changes on self-care behaviour, the European heart failure self-care 
behaviour scale was used, and it consists of the following 12 items:13 
 
I1. I weigh myself every day 
I2. If I get short of breath, I take it easy 
I3. If my shortness of breath increases, I contact my doctor or nurse 
I4. If my feet/legs become more swollen than usual, I contact my doctor or nurse 
I5. If I gain 2 kg in 1 week, I contact my doctor or nurse 
I6. I limit the amount of fluids I drink (not more than 1.52 l/day) 
I7. I take a rest during the day 
I8. If I experience increased fatigue, I contact my doctor or nurse 
I9. I eat a low salt diet 
I10. I take my medication as prescribed 
I11. I get a flu shot every year 
I12. I exercise regularly 
 
Each item was scored from “(1) I completely agree” to “(5) I do not agree at all”. As 
with the QoL questionnaire, two scores were obtained, one at the beginning and one at 
the end of the telehealth programme. Significant differences (p<0.05) were found in 
some of the items. Moreover, the telehealth programme showed a general improvement 
in the self-care behaviour. This can be seen in Figure 5, where the comparison between 
the scores at the beginning and end are indicated for the total score and for the items 
with significant differences (p<0.05). These results were equal for both telehealth 
systems, where no significant differences (p>0.05) were found. 
 
An important observation here is the fact that significant differences (p<0.05) were 
found in the scores for I1 and I6, which correspond to “measuring body weight every 
day” and “limiting the amount of daily fluid intake”. These two factors are very 
important in the monitoring of HF. Hence, when the patients with decreasing trend in 
DBP (136 patients), SBP (131 patients), and weight (91 patients) were analysed, and 
their scores at day 1 and day 42 were compared, it was possible to observe an 
improvement in their self-care behaviour. This improvement was more obvious in the 
daily weighing and in the daily fluid intake (see Figure 6).  
 
Interventions 
Different interventions were annotated in the dataset, and some significant differences 
were found between both telehealth systems. It was observed that patients using the 
Docobo unit received 2% more diuretic titration, 3% less titration of beta blockers, and 
2% less titration of angiotensin-converting enzyme inhibitors than Motiva patients. 
Unfortunately, no information about the exact dose of medication nor differentiation 
between up- and down-titration was available.  
Another important observation that can be made, is that 6 out of 135 patients using 
Docobo withdrew the programme, while only 2 out of 399 withdrew when using Motiva 
platform. After evaluating these proportions using the Chi-square test, a significant 
difference was found with p=0.004.  
 
Discussion 
 
The results of this study indicate that the characteristics of the telehealth platform have 
an effect on the compliance of the patients to the telehealth programme. This is supported 
by the amount of missing data, and by the withdrawal rates of both systems. In other 
words, a platform such as the Motiva system, which offers educational information and 
a more user friendly interface, might increase the compliance and adherence of the 
patients to the programme, and this on its turn could have a long term effect on the 
evolution of the patients’ condition. In this study, after only 42 days of monitoring, it 
was already possible to see differences in the evolution of blood pressure. Nevertheless, 
it may be speculated that these differences could have been caused by differences in 
titration between both telehealth systems. Unfortunately, no information on medication 
nor on exact doses was available during this study. Therefore, in order to draw stronger 
conclusions on the effect of either telehealth platform on patients’ outcome, it is 
necessary to implement longer trials where information about medication changes is 
available. In addition, longer-term trials will also allow to assess changes in the quality 
of life of patients using telehealth.  
Having considered the effect of the user interfaces on the evolution of the physiological 
parameters, it is now important to comment on the behavioural changes observed in this 
study. It was shown that a general improvement in the self-awareness, self-management 
and assistance-seeking was achieved by the telehealth programme. This is a remarkable 
finding, because it proves that by implementing a telehealth programme, it is possible to 
increase the awareness of patients of the importance of self-managing their conditions. 
For instance, daily weighing and limitation of daily fluid intake became an important 
factor for patients during the monitoring period. Hence, significant improvements in a 
long term can be achieved, such as better adherence to telehealth programmes that can 
result in a reduction of heart failure decompensations.  
Despite the fact that patients were more aware of the importance of monitoring their 
weight, it was observed that measurements of this parameter were often missing. This 
was the case even for patients using the telehealth system more than twice a day. These 
findings are crucial, since weight is a very important parameter in HF, and it has been 
shown to be probably the most useful physiological parameter to predict 
decompensations.5,15 Therefore, it is important to keep in mind that patients tend to 
forget, or simply avoid to take daily measurements of weight, when developing 
telehealth systems, and when designing algorithms for risk prediction. It is worth noting 
that attention must be paid to the way weight measurements are integrated into the 
telehealth system. For example, a way where all sensors are integrated into one compact 
platform could be developed, as well as new protocols to attract and motivate patients to 
monitor themselves on a daily basis.  
Two important points must be considered here. On the one hand, the Motiva unit uses a 
“well-known” interface, i.e. the television, and on the other hand, the mean age of the 
population under investigation was 69.1yr±12.6yr. These two points are crucial because 
elderly people of today are more used to the TV technology, while the HF population of 
10 or 20 years will already be used to more portable devices, e.g. standalone units. 
Hence, it is believed that technological differences may cause that patients using the 
Motiva system are reminded more often to take daily measurements, while patients using 
standalone units tend to comply less with the monitoring times. However, these results 
will probably change in the future due to the fact that society is relying more and more 
on portable devices. These findings are in agreement with the increasing needs for 
personalized health informatics,16 where each telehealth system is specifically tuned to 
work for each particular patient. 
 
 
Conclusions 
 
This study assessed changes in the evolution of blood pressure, pulse, blood oxygen 
saturation, weight, and self-care behaviour caused by the implementation of a telehealth 
programme on HF patients. Two telehealth systems were used to monitor patients, 
namely the Motiva platform offered by Philips, and the Docobo unit. Both patient groups 
were monitored by the same healthcare providers, and the main difference between both 
systems was the user interface, and the amount of educational information that was 
presented to the patients. Significant differences were found between both systems, as 
well as a possible positive effect of education on the compliance and adherence of the 
patients to the telehealth programme. This effect will need to be confirmed in future 
studies, where information of how often patients access educational material is available. 
 
A general improvement in the self-care behaviour was achieved by the use of telehealth, 
which appeared to also have a positive effect on the evolution of the physiological 
parameters. Therefore, an improved heart failure outcome can be achieved, which may 
lead to a reduced load in the healthcare system. Nevertheless, this is something that needs 
to be confirmed by longer-term trials, where hospitalizations are included as endpoints.  
 
One of the main limitations of this study was the lack of information about types of 
medication and dose changes. For this reason, no links between changes in the 
physiological parameters and medication could be made. Furthermore, the short-term 
duration of this study, namely 42 days per patient, limited the possibility to observe 
clinical events. Therefore, no conclusions on the effect of each telehealth system on the 
outcome could be drawn.  
 
The results obtained in this study allow to define some practicalities and technicalities 
that need to be considered when designing and implementing a telehealth system, and 
they will be listed next. 
- The telehealth device needs to be considered because it has a direct influence 
in the compliance of the patients to the programme. For some patients the 
mobility of the unit is important, while for others the fact that they do not need 
to use or learn a “new” technology improves their compliance to the 
monitoring times.   
- The educational and additional information presented to the patients should be 
included in the telehealth programme. 
- A way to attract and motivate patients to take daily measurements of weight 
needs to be reconsidered. This is crucial for the design of algorithms that 
predict decompensation due to heart failure. 
- It is of paramount importance to include information about medication and 
doses in order to assess the direct effect of telehealth on the evolution and final 
outcome of the patients. 
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Table 1. Main characteristics of the telehealth systems 
Docobo Motiva 
Stand-alone unit Interactive telehealth platform 
No video streaming Personal healthcare channel 
No educational information Educational information to control and 
understand the condition 
Blood pressure (systolic/diastolic) Blood pressure (systolic/diastolic) 
Pulse rate Pulse rate 
Oxygen saturation (SpO2) Oxygen saturation (SpO2) 
Body weight Body weight 
 
 
 
 
Figure 1. Heart failure patients on the telehealth programme. 
534 randomized 
135 Randomized to receive Docobo units 
2 excluded (ongoing monitoring) 
399 Randomized to receive Motiva systems 
 31 excluded (ongoing monitoring) 
105 included in the Docobo group 
2 Withdrew consent 
1 Referred to other agencies 
5 Lost to follow-up 
1 Equipment failure 
306 included in the Motiva group 
6 Withdrew consent 
3 Referred to other agencies 
4 Lost to follow-up 
1 Equipment failure 
  
 
 
 
Figure 2. Amount of data transmitted to the hospitals for each telehealth system. Note that patients with 
Motiva unit seem to comply better with the programme. Differences in DBP, SBP and Pulse for more than 
2 measurements a day were significantly different (p<0.05). Concerning the days without measurement, 
Weight indicated a significant difference (p<0.05). The central mark of the boxplots is the median, and the 
edges correspond to the 25th and 75th percentiles. 
 
 
 
Figure 3. Physiological parameters at day 1 (left) and age (right) of the patients in both groups under 
investigation. The central mark of the boxplots is the median, and the edges correspond to the 25th and 
75th percentiles. 
 
 
 
Figure 4. Slopes for each physiological parameter and for each telehealth system. Diastolic blood pressure 
tends to decrease in patients using Motiva (p=0.001). Pulse and weight also tend to decrease in those 
patients. However, no significant differences were found. The central mark of the boxplots is the median, 
and the edges correspond to the 25th and 75th percentiles. 
 
 
 
 
 
 
Figure 5. Scores of the self-care behaviour questionnaire for all the patients under investigation. All 
differences were significant (p<0.05). The central mark of the boxplots is the median, and the edges 
correspond to the 25th and 75th percentiles. 
 
 
 
 Figure 6. Scores of items 1 and 6. Significant differences (p<0.05) were found between the scores for 
patients with decreasing trends in DBP, SBP and Weight. The central mark of the boxplots is the median, 
and the edges correspond to the 25th and 75th percentiles. 
 
 
 
